BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10358454)

  • 1. [CA 125 in the department of internal medicine--a marker of ovarian tumor, thoracic fluid or ascites?].
    Kasalický P; Kocián J
    Vnitr Lek; 1998 Aug; 44(8):478-80. PubMed ID: 10358454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum CA-125 levels: hepatitis or ascites?
    Sevinc A; Buyukberber S; Sari R
    Gynecol Oncol; 2000 Jan; 76(1):141-2. PubMed ID: 10620461
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study.
    Topalak O; Saygili U; Soyturk M; Karaca N; Batur Y; Uslu T; Erten O
    Gynecol Oncol; 2002 Apr; 85(1):108-13. PubMed ID: 11925128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic struma ovarii presenting with ascites and an elevated CA-125 level. A case report.
    Bokhari A; Rosenfeld GS; Cracchiolo B; Heller DS
    J Reprod Med; 2003 Jan; 48(1):52-6. PubMed ID: 12611097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A clinical evaluation of CA 125 levels in serum, ascites and pleural effusion].
    Jibiki K; Demura R; Abe Y; Odagiri E; Demura H
    Gan No Rinsho; 1987 Nov; 33(14):1756-62. PubMed ID: 3480363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Benign ovarian tumor with ascites and high serum levels of CA125: report of 3 cases].
    Li HJ; Shen K; Lang JH; Wu M; Huang HF; Pan LY
    Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):147-9. PubMed ID: 12816688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High Ca 125 serum level in benign ascites or pleural effusion].
    Mezger J; Häussinger KE; Wilmanns W; Lamerz R
    Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):463-5. PubMed ID: 3476336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
    Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
    Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. False positivity of tumor markers in pleural fluid of traumatic hemothorax.
    Foresti V; Parisio E; De Filippi G
    Recenti Prog Med; 1992 May; 83(5):295-7. PubMed ID: 1439110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum CA-125 levels in hemodialysis patients with peritoneal, pleural, or pericardial fluids.
    Sevinc A; Buyukberber S; Sari R; Kiroglu Y; Turk HM; Ates M
    Gynecol Oncol; 2000 May; 77(2):254-7. PubMed ID: 10785474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of tumor marker CA 125 in the treatment of ovarian cancer].
    Porsbjerg CM; Sørensen JB; Lund BA
    Ugeskr Laeger; 1998 Feb; 160(7):995-1000. PubMed ID: 9477746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hairy cell leukaemia presenting with ascites, pleural effusion and increased CA 125 serum level.
    Dinçol G; Doğan O; Küçükkaya RD; Gül E; Kahraman R; Ağan M
    Neth J Med; 2008 Jan; 66(1):23-6. PubMed ID: 18219064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benign ovarian fibroma associated with free peritoneal fluid and elevated serum CA 125 levels.
    Spinelli C; Gadducci A; Bonadio AG; Berti P; Miccoli P
    Minerva Ginecol; 1999 Oct; 51(10):403-7. PubMed ID: 10638167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian capillary hemangioma presenting as an adnexal mass with massive ascites and elevated CA-125.
    Gehrig PA; Fowler WC; Lininger RA
    Gynecol Oncol; 2000 Jan; 76(1):130-2. PubMed ID: 10620457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ovarian cancers and CA 125 in 2006].
    Lambaudie E; Collinet P; Vinatier D
    Gynecol Obstet Fertil; 2006 Mar; 34(3):254-7. PubMed ID: 16529967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian cancer tumor marker behavior in asymptomatic healthy women: implications for screening.
    Crump C; McIntosh MW; Urban N; Anderson G; Karlan BY
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1107-11. PubMed ID: 11045795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumour markers in epithelial ovarian cancer].
    Sparholt MH; Høgdall E; Høgdall CK
    Ugeskr Laeger; 2009 Nov; 171(48):3505-9. PubMed ID: 19944049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cancer antigen-125 from pleural & ascitic fluid samples in non malignant conditions.
    Kalantri Y; Naik G; Joshi SP; Jain A; Phatak S; Chavan R; Hemvani N; Chitnis DS
    Indian J Med Res; 2007 Jan; 125(1):25-30. PubMed ID: 17332654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CA-125 antigen].
    Zakrzewska I
    Postepy Hig Med Dosw; 2002; 56(1):29-38. PubMed ID: 11987487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometriosis mimicking advanced ovarian cancer.
    Goumenou A; Matalliotakis I; Mahutte N; Koumantakis E
    Fertil Steril; 2006 Jul; 86(1):219.e23-5. PubMed ID: 16818037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.